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ORIGINAL PAPER / GYNECOLOGY
Endoglin promotes cell migration and invasion in endometriosis by regulating EMT
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ABSTRACT
Objectives: This study aims to investigate the expression and role of Endoglin (ENG) in 
endometriosis (EM). 
Material and methods: In this study, quantitative real-time polymerase chain reaction, 
western blot and immunohistochemistry were used to examine the expression of ENG in 
tissues. Cellular experiments were performed to evaluate the effect of ENG on cellular 
biological function. Western blot was used to examine the expression of epithelial to 
mesenchymal transition-related proteins. 
Results: The expression of ENG was significantly higher in the ectopic endometriotic 
tissues than that in eutopic endometriotic tissues. Knockdown of ENG inhibited cell 
viability, migration and invasion, and induced cell apoptosis in hEM15A cells. 
Additionally, silenced ENG caused increased levels of E-cadherin and decreased levels of
N-cadherin, vimentin, MMP-2 and MMP-9. 
Conclusions: These results confirmed that ENG may be involved in the development of 
endometriosis by promoting EMT process, revealing a new insight into the pathogenesis 
of endometriosis and contributing to the exploration of molecular therapeutic strategies 
against endometriosis.








Endometriosis is an estrogen-dependent chronic gynecological disease. Menstrual
cramps, pelvic pain, infertility and other problems caused by endometriosis seriously 
affect women's quality of life and fertility [1]. To date, 20% to 50% of postoperative 
recurrence rate and long-term side effects of medication lead to huge physical and mental
pain and economic burden for patients [2, 3]. Therefore, in-depth study of the 
pathogenesis of endometriosis is crucial for intervention and treatment.
Endoglin (ENG, also known as CD105) is a 90 kDa type I transmembrane 
glycoprotein which is highly expressed in the vascular endothelium and plays an 
important role in the regulation of angiogenesis [4]. ENG has been proved to enhance 
tumor angiogenesis by acting as a coreceptor for transforming growth factor-β (TGF-β) 
signaling, and targeting ENG exhibits strong inhition of tumor invasion, angiogenesis and
tumor metastasis [5, 6]. The formation of endometriosis ectopic lesions is very similar to 
the process of tumor metastasis. ENG has been reported to be upregulated in the eutopic 
and ectopic endometrium of women with   endometriosis compared with control 
endometrium and plays a vital role in endometriotic angiogenesis [7, 8]. However, the 
molecular mechanism of ENG in endometriosis remains unclear.
Objectives
In this study, we aim to investigate the expression, biological function and 
potential mechanism of ENG in endometriosis (EM).
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MATERIAL AND METHODS
Patients and tissue samples
In this study, we enrolled a total of 30 patients with advanced stage ovarian 
endometriosis (17 ASRM stage III and 13 stage IV) who underwent laparoscopic surgery 
in the department of gynecology of People’s Hospital of Anji. The pathology of 
endometriosis was diagnosed with tissues analyzed by histopathology to confirm the 
presence of endometrial stroma and glands. The normal endometrial tissues were 
obtained from 25 healthy fertile women who underwent operative treatment for uterine 
myoma or cervical intraepithelial neoplasia (CIN) other than endometriosis. They had not
received hormone therapy for at least three months before sampling, and none of them 
had visible endometrial hyperplasia or neoplasia and inflammatory disease at the time of 
clinical examination or laparoscopy. The study protocol was approved by the ethics 
committee of People’s Hospital of Anji, and informed written consent was obtained from 
all participants.
Quantitative real-time polymerase chain reaction (qRT-PCR)
The expression of ENG mRNA in EM and normal endometrial ( EN) tissues was 
examined by qRT-PCR. Total RNA was isolated from the ectopic and normal endometrial
tissues using Trizol (Invitrogen, USA), and then reversely transcribed into cDNA using 
SuperScript™ III reverse transcriptase (Invitrogen, USA). qRT-PCR was performed using
the Universal SYBR Green Master kit. The levels of ENG were normalized to GAPDH 
and calculated by 2−ΔΔCt method.
Western blot
Western blot was conducted to examine the expression of ENG protein in EM and
EN tissues. Total protein was extracted with radioimmunoprecipitation assay (RIPA) lysis
buffer, separated using SDSsodium dodecyl sulfate-polyacrylamide gel electrophoresis 
(SDS-PAGE) and transferred onto polyvinylidene difluoride (PVDF) membranes 
(Millipore Co., USA). Immunoblotting was performed with primary antibodies. The 
PVDF membranes were incubated with secondary antibody, and then developed using 
ECL chemiluminescence assay kit (Proteintech, China) and analyzed by the ChemiDoc™
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XRS imaging system. Anti-endoglin antibody was purchased from Abcam, anti-E-
cadherin, anti-N-cadherin, anti-vimentin, anti-MMP-2, anti-MMP9 and anti-GAPDH 
antibodies were obtained from Proteintech (Shanghai, China).
Immunohistochemistry (IHC)
IHC was performed to detect the intracellular expression and location of ENG. 
The formalin-fixed, paraffin-embedded section samples were dewaxed in xylene and 
hydrated in graded ethanol series, followed by antigen repair with repair solution. The 
tissues were then blocked endogenous peroxidase activity using 3% H2O2. Subsequently, 
anti-endoglin antibody and secondary antibodies were added, followed by DAB staining 
and hematoxyline restaining. Finally, cells were observed under the microscope. 
Cell culture and transfection 
Human immortalized eutopic stromal cell line hEM15A was purchased from 
China Center for Type Culture Collection (Wuhan, China). Cells were cultured in DMEM
medium (Gibco, USA) containing 10% FBS. 
To knock down the intrinsic expression of ENG in cells, shRNA targeting ENG 
was used to transfect cells as follows. A total of 3 × 105 hEM15A cells were seeded in six-
well plates, cultured for 24 hours, and then transfected with shRNA targeting human 
ENG (sh-ENG) or shRNA negative control (sh-NC) by using Lipofectamine 3000 
(Invitrogen, Carlsbad, CA) according to the instruction of the manufacturer.
Cell counting kit-8 assay (CCK-8) 
The viability of hEM15A cells was examined using CCK8 assay. Briefly, a total 
1.0 × 106 of hEM15A cells were seeded into 96-well plates and subjected to indicated 
treatments. After 24, 48 and 72 hours, 10 µL of CCK8 reagent was used and incubated 
for four hours at 37 °C. The absorbance value at 450 nm was detected by enzyme-labeled
instrument.
Cell apoptosis assay
The Annexin V-FITC/PI Apoptosis Detection Kit (Yeasen, Shanghai, China.) was 
used to evaluate cell apoptosis. hEM15A cells were collected, washed with PBS, and 
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resuspended in binding buffer. Subsequently, cells were stained with FITC-labeled 
annexin V and propidium iodide (PI) for 15 min at room temperature in darkness. Finally,
the stained cells were analyzed by the flow cytometry BD FACSDiva 6.1 software. 
Wound healing assays
Wound healing assay was performed to assess the migratory capacity of hEM15A 
cells. Cells were seeded into a six-well plate. When the cells merged into a monolayer, 
the scratch was made with a 200-µl sterile pipette tip. The cells were then washed for 
three times to remove the cell debris and cultured in complete DMEM for 24 hours. After
the medium was removed, serum-free DMEM was added. The wound was observed and 
photographed at the indicated times with an inverted microscope (Olympus Corporation) 
and analyzed using ImageJ software. All assays were performed three times in our study.
Transwell assay
The migratory and invasive capacities of hEM15A cells were assessed using 
transwell assays. For migration assay, we added 4 × 104 cells in 200 µL of serum-free 
DMEM in the upper chamber and then placed 500 µl of DMEM containing 30% FBS to 
the lower chamber. For invasion assays, we precoated the chamber inserts with 50 µL of 
1:6 mixture of Matrigel (BD Biosciences) and DMEM for about two hours in a 37 °C 
incubator. Then we seeded 8 × 104 cells in the upper chamber. The lower chamber also 
added 500 µl of DMEM containing 30% FBS. After cultured for 48 h, the migrated cells 
were fixed with 4% paraformaldehyde and stained with crystal violet. Five random 100× 
microscopic fields were selected to count the stained cells by using an inverted 
microscope (Olympus Corporation). 
Statistical analysis
All experiments were performed in triplicate. data were expressed as means ± SD 
and analyzed by Student’s t-test, one- or two-way analysis of variance (ANOVA) using 
SPSS 21.0 software. The bar or scatter chart were showed using GraphPad Prism 




Our data showed that the expression of ENG mRNA in EM tissues (n = 30) was 
significantly higher than that in EN tissues (n = 25) (p < 0.001) (Fig. 1A), while there 
was no difference in ENG expression between EM of different stage (Fig. 1B). 
Consistently, western blot analysis showed that ENG protein levels were upregulated in 
EM tissues compared with the EN group (Fig. 1C) (p < 0.001). Further, we observed that 
ENG was mainly located in the glandular and the luminal stromal cells in the 
endometriosis tissues (Fig. 1D). These data suggest that ENG may be involved in the 
development and progression of endometriosis.
To further explore the biological function of ENG in endometriosis, hEM15A 
cells were transfected with ENG-shRNA or control shRNA. As shown in Figure 2A, 
transfection of cells with ENG-shRNA efficaciously decreased the expression of ENG 
compared with the control group. CCK-8 assay showed that down-regulated ENG 
significantly inhibited hEM15A cells proliferation at 48 and 72 hours compared with the 
control group, whereas there was no significant difference between sh-NC and control 
group (p < 0.05) (Fig. 2B). Further, results of flow cytometry analysis showed that down-
regulated ENG markedly induced hEM15A cell apoptosis by 9.03% compared with the 
control group (p < 0.001) (Fig. 2C). Moreover, western blot analysis showed that down-
regulated ENG could remarkably reduce bcl-2 expression and elevated the levels of bax 
and cleave-caspase-3 proteins (Fig. 2D), which confirmed the promoting effect of down-
regulated ENG on apoptosis. These data suggest ENG knockdown can inhibit 
proliferation and promote apoptosis of hEM15A cells.
Further, the results of wound healing assay showed that down-regulated ENG 
noticeably decrease the migratory rate by 29.63% ± 0.63% compared with the control 
group (p < 0.05) (Fig. 3A). Furthermore, transwell assays showed that down-regulated 
ENG significantly inhibited ectopic endometrial stromal cell migratory and invasive 
capacities compared with the control groups, whereas there was no significant difference 
between sh-NC and control groups (Fig. 3B and C). These data suggest ENG knockdown 
can inhibit migration and invasion of hEM15A cells.
The epithelial to mesenchymal transition (EMT) has been implicated as a key 
regulator of cell proliferation, apoptosis, and metastasis and is activated in endometriosis,
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suggesting the involvement of EMT in the disease. As described in Figure 3D, ENG 
knockdown significantly inhibited the expression of N-cadherin, vimentin, matrix 
metalloproteinase (MMP)-2 and MMP-9 and increased E-cadherin expression in ectopic 
endometrial stromal cells compared with the control groups, whereas sh-NC transfection 
had no effects on EMT-related proteins compared with the control groups (Tab. 1). These 
data indicate ENG knockdown can inhibit EMT process in endometriosis.
DISCUSSION
Endometriosis is manifested by ectopic implantation of endometrial cells tissue 
outside the uterine cavity and may cause symptoms, which include chronic pelvic pain, 
bleeding, infertility, and an increased susceptibility to development of adenocarcinoma
[9]. However, the pathogenesis of endometriosis has not been fully elucidated. In this 
study, we found that ENG was upregulated in ectopic endometrial tissues from patients 
with endometriosis compared with normal endometrial tissues, suggesting that ENG 
plays a vital role in the development of endometriosis. Subsequently, a series of cell 
experiments showed that ENG knockdown could induce cell apoptosis and inhibit cell 
proliferation, migration, invasion in hEM15A cells. Furthermore, ENG knockdown led to
the changes of EMT-related proteins, indicating ENG may be involved in endometriosis 
through regulating EMT process.
In this study, we found up-regulated ENG in endometriotic tissues. Further, we 
showed that down-regulated ENG by shRNA could induce cell apoptosis and promote 
cell viability, migration and invasion in hEM15A cells. It is well known that ENG is 
involved in tumor microvessel growth, metastasis, drug-resistance in many solid tumors, 
whereas targeting ENG exhibits a significant anti-tumor effect [10–13]. Similar to our 
findings, few studies have reported that the expression of ENG was significantly 
increased in endometriotic tissues and has been identified as an active player in the 
process of endometriotic angiogenesis [7, 14, 15]. However, the biological function and 
underlying mechanism of ENG in endometriosis has not been clearly clarified. 
It has been reported that ENG plays an important biological role in EMT process. 
Mercado-Pimentel et al. [16], showed that ENG directly participated in the process of 
EMT through interacting with both TGFß-regulated activation and invasion pathways 
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during cardiac valve formation, whereas inhibition of ENG expression could directly 
perturb EMT process and decrease the expression of EMT markers including slug, runx2,
RhoA, and latrophilin-2. Hu et al. [17] found that ENG positive renal tumor-initiating 
cells distinctly exhibit upregulated N-cadherin and vimentin and negligible E-cadherin in 
comparision with the unselected parental tumor cells. Silencing ENG could increase E-
cadherin level and decrease the levels of vimentin and N-cadherin and inhibit cell 
invasion and motility. Consistent with these previous studies, our results showed that 
knockdown of ENG could increase epithelial marker E-cadherin expression and decrease 
the expression of mesenchymal markers N-caherin and vimentin in hEM15A cells. In 
addition, we also found silencing ENG attenuated the levels of MMP2 and MMP9 that 
are the major proteases in extracellular matrix degradation. EMT endows cells with 
migratory and invasive properties, which are also considered to be prerequisites for the 
original establishment of endometriotic lesions. The mesothelial cells that have 
undergone EMT no longer provide a lamellar protective barrier between the basal layer 
and the lumen. In the absence of the mesothelial barrier, endometrial cells readily adhere 
to the subperitoneum and form endometriosis. Many studies on endometriosis invasion 
and fibrosis have also shown the importance of EMT [18-21]. Therefore, based on all 
findings, we speculate that ENG may promote cell migration and invasion by regulating 
EMT phenotype in endometriosis.
CONCLUSIONS
In conclusion, we observe that ENG expression is upregulated in endometriosis 
tissues and silencing ENG inhibits proliferation, migration, invasion and induces 
apoptosis through modulation of EMT in endometriosis. These results reveal new insights
into the pathogenesis of endometriosis and contribute to the exploration of molecular 
therapeutic strategies against endometriosis.
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Table 1. The expression of EMT-related proteins in hEM15A cells after knockdown of 
ENG
　 Control sh-NC sh-ENG p value
E-cadherin 0.3587 ± 0.0070 0.3403 ± 0.0131 0.8683 ± 0.0140 < 0.001
N-cadherin 0.5483 ± 0.0192 0.5380 ± 0.0181 0.1993 ± 0.0125 < 0.001
Vimentin 0.8637 ± 0.0141 0.8220 ± 0.0217 0.3183 ± 0.0133 < 0.001
MMP2 0.4747 ± 0.0119 0.4597 ± 0.0059 0.2203 ± 0.0180 < 0.001
MMP9 0.7690 ± 0.0167 0.7470 ± 0.0191 0.2327 ± 0.0075 < 0.001
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Figure 1. ENG expression was increased in ectopic endometrial tissues; A. qRT-PCR was
used to detect ENG mRNA expression in endometriosis and normal endometrial tissues; 
B. The expression of ENG in stage III and IV endometriosis, revealed by qRT-PCR. C. 
Western blot was performed to measure ENG protein level. IHC was carried out to 
examine the intracellular expression and location of ENG, and the most representative 
results were shown; EN — normal endometrium; EM — ectopic endometrium; *** p < 
0.001 as compared with EU groups; ns — no significance
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Figure 2. ENG knockdown inhibited proliferation and induced apoptosis of hEM15A 
cells; A. qRT-PCR and western blotting were used to detect ENG expression in hEM15A 
cells transfected with sh-ENG or sh-NC. The effects of ENG knockdown on cell 
proliferation B. and apoptosis C. were measured by CCK8 and flow cytometry analysis; 
D. Cell apoptosis-related proteins were detected by western blot; *p < 0.05; **p < 0.01 
and ***p < 0.001 as compared with the control groups 
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Figure 3. ENG knockdown regulated migration and invasion and EMT-related proteins 
of hEM15A cells; A. Wound healing was performed to assess cell migratory ability. 
Transwell assay were used to asses B. cell migratory and C. invasive ability; D. Western 
blot was used to measure the expression of EMT-related proteins, including N-cadherin, 
Vimentin, MMP-2, MMP-9 and E-cadherin; ***p < 0.001 as compared with the control 
groups
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